Beyond Hemophilia: How Bleeding Disorder Therapy and Recombinant Clotting Factors Are Saving Lives
While often associated primarily with congenital hemophilia, Bleeding disorder therapy encompasses a much broader spectrum of conditions, including acquired hemophilia, von Willebrand disease (VWD), and trauma-induced coagulopathy. The role of Recombinant clotting factors, particularly recombinant factor VIIa (rFVIIa), extends beyond routine hemophilia care to serve as a critical...
0 Comments 0 Shares 4 Views 0 Reviews